73914

Sphingosin-1-phosphat

≥98.0% (TLC)

• Synonym(e): (2S,3R,4E)-2-Amino-4-octadecen-1,3-diol-1-phosphat, D-Erythro-Sphingosin-1-Phosphat
• Empirische Formel (Hill-System): C₁₈H₃₈NO₅P
• CAS-Nummer: 26993-30-6
• Molekulargewicht: 379.47
• MDL-Nummer: MFCD00270077
• UNSPSC-Code: 12352211
• PubChem Substanz-ID: 329765332
• NACRES: NA.85

Eigenschaften

• Qualitätsniveau: 100
• Assay: ≥98.0% (TLC)
• Form: powder
• Zusammensetzung: carbon content, 56.97% ; hydrogen content, 10.09% ; nitrogen content, 3.69%
• Lipid-Typ: sphingolipids
• Lagertemp.: −20°C
• SMILES String: CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)COP(O)(O)=O
• InChI: 1S/C18H38NO5P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(20)17(19)16-24-25(21,22)23/h14-15,17-18,20H,2-13,16,19H2,1H3,(H2,21,22,23)/b15-14+/t17-,18+/m0/s1
• InChIKey: DUYSYHSSBDVJSM-KRWOKUGFSA-N

Beschreibung

Anwendung

Repurposing Siponimod for osteoporosis: A study highlighted the potential of Siponimod, an S1P receptor modulator originally developed for multiple sclerosis, to treat osteoporosis by influencing Sphingosine 1-phosphate pathways (Hu et al., 2024).

Sphingosine-1-phosphate in ocular health: Research demonstrated that a selective agonist for Sphingosine-1-phosphate receptor 1/5 could mitigate ocular vascular pathologies, suggesting therapeutic potentials in eye disease management, it is also responsible for regulating various intracellular processes, including cell survival, differentiation, and proliferation (Nakamura et al., 2024).

Targeting diabetic kidney disease: The study investigated how Plantaginis Semen, through the sphingosine kinase 1/Sphingosine-1-phosphate pathway, could ameliorate diabetic kidney disease, underscoring the pathways role in metabolic health (Lan et al., 2024).

Advancements in neurodegenerative disease treatments: A review focused on the development of small-molecule modulators targeting Sphingosine-1-phosphate receptors, presenting new directions in treating neurodegenerative diseases (Sankar Kar et al., 2024).

Biochem./physiol. Wirkung

Ein lipidischer sekundärer Botenstoff, der an S1P₁ und S1P₃-Rezeptoren bindet. Mobilisiert intrazelluläre Ca²⁺-Lager und verringert zelluläres cAMP. Aktiviert Phospholipase D. S1P stimuliert die Migration von Endothelzellen, hemmt aber die Migration von anderen Zelltypen. Induziert Angiogenese.

Verpackung

Bodenlose Glasflasche. Der Inhalt befindet sich innerhalb des eingeschobenen Schmelzkegels.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable